MA
AMPE

MUFG Americas’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

MUFG Americas’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6
Closed – – 947
2022
Q2 		$0 Hold
6
– – ﹤0.01% 828
2022
Q1 		$1K Hold
6
– – ﹤0.01% 801
2021
Q4 		$1K Hold
6
– – ﹤0.01% 812
2021
Q3 		$3K Hold
6
– – ﹤0.01% 817
2021
Q2 		$3K Hold
6
– – ﹤0.01% 668
2021
Q1 		$3K Hold
6
– – ﹤0.01% 663
2020
Q4 		$3K Hold
6
– – ﹤0.01% 691
2020
Q3 		$2K Hold
6
– – ﹤0.01% 645
2020
Q2 		$1K Hold
6
– – ﹤0.01% 665
2020
Q1 		$1K Hold
6
– – ﹤0.01% 702
2019
Q4 		$1K Hold
6
– – ﹤0.01% 727
2019
Q3 		$1K Hold
6
– – ﹤0.01% 740
2019
Q2 		$1K Hold
6
– – ﹤0.01% 761
2019
Q1 		$1K Hold
6
– – ﹤0.01% 869
2018
Q4 		$1K Buy
+6
New +$921 ﹤0.01% 721

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

MUFG Americas's AMPE Position: Q3 2022 in Review

MUFG Americas sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q3 2022, closing a stake of 6 shares.

MUFG Americas first reported a position in AMPE in Q4 2018 and held it in 15 quarters. The position peaked at $3K in Q3 2021. 95 funds tracked by Wall St. Rank hold AMPE as of Q3 2022.

  • MUFG Americas reported no remaining Ampio Pharmaceuticals Inc. position as of Q3 2022 after selling out during the quarter.
  • MUFG Americas sold 6 Ampio Pharmaceuticals Inc. shares in Q3 2022.
  • MUFG Americas first reported a position in Ampio Pharmaceuticals Inc. in Q4 2018 and held it in 15 quarters.
  • MUFG Americas's Ampio Pharmaceuticals Inc. position peaked at $3K in Q3 2021.
  • 95 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q3 2022.

Based on MUFG Americas's 13F filing for Q3 2022, filed 1 Nov 2022.